Bortezomib administered subcutaneously is well tolerated in bortezomib-based combination regimens used in patients with multiple myeloma.

Bortezomib administered subcutaneously is well tolerated in bortezomib-based combination regimens used in patients with multiple myeloma.

Item
http://www.wikidata.org/entity/Q33410637
Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myeloma.Peripheral neuropathy outcomes and efficacy of subcutaneous bortezomib when combined with thalidomide and dexamethasone in the treatment of multiple myeloma.Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myelomaSubcutaneous bortezomib for multiple myeloma treatment: patients' benefits.Recurrent Body Rash Warranted Second Desensitization With Acyclovir in a Myeloma Patient: A Case Report.Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma.Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices.
P2860

Bortezomib administered subcutaneously is well tolerated in bortezomib-based combination regimens used in patients with multiple myeloma.

Item
http://www.wikidata.org/entity/Q33410637
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Bortezomib administered subcut ...... atients with multiple myeloma.
@ast
Bortezomib administered subcut ...... atients with multiple myeloma.
@en
type
label
Bortezomib administered subcut ...... atients with multiple myeloma.
@ast
Bortezomib administered subcut ...... atients with multiple myeloma.
@en
prefLabel
Bortezomib administered subcut ...... atients with multiple myeloma.
@ast
Bortezomib administered subcut ...... atients with multiple myeloma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Bortezomib administered subcut ...... atients with multiple myeloma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698